C.R. Bard Inc. (NYSE:BCR) will pay $184 million to settle most of the lawsuits against subsidiary Davol Inc.’s hernia repair products. Through late last year, more than 2,700 plaintiffs had filed suit in either federal or state courts pursuing product-liability claims for personal injuries, with most of those cases since transferred to the U.S. District Court for Rhode Island. Warwick, R.I.-basedDavol Inc.subsidiary, began a recall of its Composix Kugel hernia patches in December, 2005, after receiving reports that the device broke apart inside several patients.
